Mode
Text Size
Log in / Sign up

Feedback message increased CRC screening participation in non-respondents, while offering sigmoidoscopy decreased it.

Feedback message increased CRC screening participation in non-respondents, while offering sigmoidosc…
Photo by marko marko / Unsplash
Key Takeaway
Consider feedback messages to boost CRC screening; offering sigmoidoscopy may reduce participation.

This randomized controlled trial enrolled 20,225 individuals aged 54-70 who were previous non-respondents to Florence's colorectal cancer screening program. Participants were randomized to receive either a standard invitation letter (control) or one of five interventions: standard letter plus a feedback message (F), plus a social norm message (MN), plus both messages (F+MN), an offer of sigmoidoscopy (FS) as an alternative to FIT (for ages 58-60 only), or an offer of CT-colonography (CTC) as an alternative to FIT (for ages 58-60 only). The primary outcome was screening participation within 90 days.

Participation was 5.7% in the control group. In the intervention groups, participation was 7.4% (F), 6.7% (MN), 6.6% (F+MN), 2.0% (FS), and 4.1% (CTC). The feedback message alone was associated with increased participation (adjusted odds ratio [aOR]=1.32, 95% CI: 1.10-1.57). In contrast, offering sigmoidoscopy significantly decreased participation compared to the standard FIT invitation (aOR=0.39, 95% CI: 0.27-0.54). Offering CTC resulted in participation similar to the control group among the eligible 58-60-year-old subgroup, and CTC participation was twice that of FS participation.

Safety, tolerability, and adverse event data were not reported. The study has several key limitations. It measured only short-term (90-day) participation and did not assess long-term adherence, cancer detection rates, or patient experience. The findings for offering alternative tests (FS and CTC) are specific to the age subgroup of 58-60 years and may not generalize to other populations or screening contexts.

For practice, this trial provides causal evidence that simple, low-cost behavioral economics interventions like feedback messages can modestly improve CRC screening uptake among previous non-responders in an organized program. However, the results caution against assuming that offering more invasive alternative tests will increase participation; in this setting, it had the opposite effect for sigmoidoscopy. The generalizability of these findings to other healthcare systems and patient populations requires further study.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Behavioural economics (BE)-inspired messages within invitations for immunochemical faecal tests (FIT), or offering alternative tests such as sigmoidoscopy (FS) or CT-colonography (CTC), are strategies to re-engage non-respondents in subsequent colorectal cancer (CRC) screening rounds. This study evaluated their impact on screening participation. METHODS: In 2022-2023, a randomized controlled trial was conducted involving 20,225 non-respondents to the CRC Florence screening program. Individuals aged 54-70 were randomized into six groups: a control group receiving the standard invitation letter (SL); three groups receiving SL plus a feedback message (F), a social norm message (MN), or both (F+MN); and two groups offered FS or CTC as alternatives to FIT among invitees aged 58-60. The primary outcome was participation within 90 days. The trial was registered with ISRCTN (ISRCTN11841256). RESULTS: Participation was 5.7% in controls, and 7.4%, 6.7%, 6.6%, 2.0%, and 4.1% in the F, MN, F+MN, FS, and CTC groups. Invitees in the F group were more likely to participate (aOR=1.32; 95%CI:1.10-1.57), while FS invitees were less likely (aOR=0.39; 95%CI:0.27-0.54). CTC participation resembled controls aged 58-60 and was twice that of FS. CONCLUSION: BE-inspired interventions can increase CRC screening participation, whereas more invasive alternative tests did not. Future studies should explore preferences for different screening tests to identify more acceptable modalities and optimise participation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.